AI-driven computational models and algorithms assist in the design of novel drugs. These methods can predict the binding affinity and activity of compounds against a target. AI enhances High-Throughput Screening (HTS) by improving the analysis of large-scale experimental data.
Clearsynth is a strategic outsourcing partner with expertise and experience to fulfill the needs of your goals. We offer comprehensive and distinctive quality services to the pharmaceutical industry and Institutions based on our experience in the field of Drug Discovery and Pharmaceuticals.
Drug development involves
large-scale and commercial
production (GMP and non-GMP) of
drug molecules.
This phase includes animal
toxicology studies and clinical
studies, regulatory submissions,
and NDA submission
Clearsynth's expertised resource and tool supports drug discovery efforts.
It helps researchers plan and execute their experiments effectively.
"From Molecules to Medicines, Faster"